Harvard chemistry professor Andrew Myers says he’s made a breakthrough that can greatly expand a class of antibiotics, forming the foundation for his latest startup: Macrolide Pharmaceuticals. And the biotech is launching today with $22 million in venture cash from an impressive group of venture backers.

…read more

Source: Harvard antibiotics spinout gets $22M in A-lister cash and Big Pharma’s attention


0 No comments